{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,7,14]],"date-time":"2024-07-14T15:35:43Z","timestamp":1720971343297},"reference-count":170,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2008,8,1]],"date-time":"2008-08-01T00:00:00Z","timestamp":1217548800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,12,7]],"date-time":"2015-12-07T00:00:00Z","timestamp":1449446400000},"content-version":"vor","delay-in-days":2684,"URL":"https:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Kidney International"],"published-print":{"date-parts":[[2008,8]]},"DOI":"10.1038\/ki.2008.166","type":"journal-article","created":{"date-parts":[[2008,6,4]],"date-time":"2008-06-04T12:39:38Z","timestamp":1212583178000},"page":"265-275","source":"Crossref","is-referenced-by-count":35,"title":["Calcimimetics in chronic kidney disease: evidence, opportunities and challenges"],"prefix":"10.1016","volume":"74","author":[{"given":"Pieter","family":"Evenepoel","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1038\/ki.2008.166_bb0010","doi-asserted-by":"crossref","first-page":"1358","DOI":"10.1038\/sj.ki.5001754","article-title":"Incidence and risk factors for hip or other bone fractures among hemodialysis patients in the Dialysis Outcomes and Practice Patterns Study","volume":"70","author":"Jadoul","year":"2006","journal-title":"Kidney Int"},{"key":"10.1038\/ki.2008.166_bb0015","doi-asserted-by":"crossref","first-page":"1434","DOI":"10.1038\/ki.1995.201","article-title":"Bone disease in predialysis, hemodialysis, and CAPD patients: evidence of a better bone response to PTH","volume":"47","author":"Torres","year":"1995","journal-title":"Kidney Int"},{"key":"10.1038\/ki.2008.166_bb0020","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1016\/S0272-6386(97)90484-4","article-title":"Effects of excess PTH on nonclassical target organs","volume":"30","author":"Bro","year":"1997","journal-title":"Am J Kidney Dis"},{"key":"10.1038\/ki.2008.166_bb0025","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1046\/j.1525-139x.2000.00074.x","article-title":"Are parathyroidectomies still appropriate in chronic dialysis patients?","volume":"13","author":"Cunningham","year":"2000","journal-title":"Semin Dial"},{"key":"10.1038\/ki.2008.166_bb0030","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1111\/j.1525-139X.2007.00300.x","article-title":"Renal osteodystrophy, phosphate homeostasis, and vascular calcification","volume":"20","author":"Hruska","year":"2007","journal-title":"Semin Dial"},{"key":"10.1038\/ki.2008.166_bb0035","doi-asserted-by":"crossref","first-page":"2131","DOI":"10.1681\/ASN.V12102131","article-title":"Association of elevated serum PO4, CaPO4 product, and parathyroid hormone with cardiac mortality risk in chronic hemodialysis patients","volume":"12","author":"Ganesh","year":"2001","journal-title":"J Am Soc Nephrol"},{"key":"10.1038\/ki.2008.166_bb0040","doi-asserted-by":"crossref","first-page":"2762","DOI":"10.1097\/01.ASN.0000034202.91413.EB","article-title":"The severity of secondary hyperparathyroidism in chronic renal insufficiency is GFR-dependent, race-dependent, and associated with cardiovascular disease","volume":"13","author":"de Boer","year":"2002","journal-title":"J Am Soc Nephrol"},{"key":"10.1038\/ki.2008.166_bb0045","doi-asserted-by":"crossref","first-page":"2208","DOI":"10.1097\/01.ASN.0000133041.27682.A2","article-title":"Mineral metabolism, mortality, and morbidity in maintenance hemodialysis","volume":"15","author":"Block","year":"2004","journal-title":"J Am Soc Nephrol"},{"key":"10.1038\/ki.2008.166_bb0050","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1111\/j.1523-1755.2005.00185.x","article-title":"Predictors and consequences of altered mineral metabolism: the Dialysis Outcomes and Practice Patterns Study","volume":"67","author":"Young","year":"2005","journal-title":"Kidney Int"},{"key":"10.1038\/ki.2008.166_bb0055","doi-asserted-by":"crossref","first-page":"1788","DOI":"10.1681\/ASN.2004040275","article-title":"Calcium, phosphorus, parathyroid hormone, and cardiovascular disease in hemodialysis patients: the USRDS Waves 1, 3, and 4 Study","volume":"16","author":"Slinin","year":"2005","journal-title":"J Am Soc Nephrol"},{"key":"10.1038\/ki.2008.166_bb0060","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1016\/S0272-6386(03)00905-3","article-title":"K\/DOQI clinical practice guidelines for bone metabolism and disease in chronic kidney disease","volume":"42","author":"National Kidney Foundation","year":"2003","journal-title":"Am J Kidney Dis"},{"key":"10.1038\/ki.2008.166_bb0065","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1097\/01.ASN.0000113243.24155.2F","article-title":"Calcium, phosphate, and parathyroid hormone levels in combination and as a function of dialysis duration predict mortality: evidence for the complexity of the association between mineral metabolism and outcomes","volume":"15","author":"Stevens","year":"2004","journal-title":"J Am Soc Nephrol"},{"key":"10.1038\/ki.2008.166_bb0070","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1007\/s00467-004-1745-0","article-title":"Treatment of secondary hyperparathyroidism of dialysis patients with calcimimetics as a valuable addition to established therapeutic means","volume":"20","author":"Dr\u00fceke","year":"2005","journal-title":"Pediatr Nephrol"},{"key":"10.1038\/ki.2008.166_bb0075","doi-asserted-by":"crossref","first-page":"F253","DOI":"10.1152\/ajprenal.00302.2004","article-title":"The calcium-sensing receptor: a key factor in the pathogenesis of secondary hyperparathyroidism","volume":"288","author":"Rodriguez","year":"2005","journal-title":"Am J Physiol Renal Physiol"},{"key":"10.1038\/ki.2008.166_bb0080","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/j.pharmthera.2005.06.019","article-title":"Pharmacological and clinical properties of calcimimetics: calcium receptor activators that afford an innovative approach to controlling hyperparathyroidism","volume":"109","author":"Nagano","year":"2006","journal-title":"Pharmacol Ther"},{"key":"10.1038\/ki.2008.166_bb0085","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1681\/ASN.2005070679","article-title":"Increased parathyroid hormone gene expression in secondary hyperparathyroidism of experimental uremia is reversed by calcimimetics: correlation with posttranslational modification of the trans acting factor AUF1","volume":"17","author":"Levi","year":"2006","journal-title":"J Am Soc Nephrol"},{"key":"10.1038\/ki.2008.166_bb0090","doi-asserted-by":"crossref","first-page":"F1390","DOI":"10.1152\/ajprenal.00262.2006","article-title":"The calcimimetic R-568 increases vitamin D receptor expression in rat parathyroid glands","volume":"292","author":"Rodriguez","year":"2007","journal-title":"Am J Physiol Renal Physiol"},{"key":"10.1038\/ki.2008.166_bb0095","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1681\/ASN.V1341017","article-title":"The calcimimetic agent AMG 073 lowers plasma parathyroid hormone levels in hemodialysis patients with secondary hyperparathyroidism","volume":"13","author":"Goodman","year":"2002","journal-title":"J Am Soc Nephrol"},{"key":"10.1038\/ki.2008.166_bb0100","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1097\/01.ASN.0000050224.03126.AD","article-title":"The calcimimetic AMG 073 as a potential treatment for secondary hyperparathyroidism of end-stage renal disease","volume":"14","author":"Quarles","year":"2003","journal-title":"J Am Soc Nephrol"},{"key":"10.1038\/ki.2008.166_bb0105","doi-asserted-by":"crossref","first-page":"1516","DOI":"10.1056\/NEJMoa031633","article-title":"Cinacalcet for secondary hyperparathyroidism in patients receiving hemodialysis","volume":"350","author":"Block","year":"2004","journal-title":"N Engl J Med"},{"key":"10.1038\/ki.2008.166_bb0110","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1111\/j.1523-1755.2005.67139.x","article-title":"Achieving NKF-K\/\/DOQI[trade] bone metabolism and disease treatment goals with cinacalcet HCl","volume":"67","author":"Moe","year":"2005","journal-title":"Kidney Int"},{"key":"10.1038\/ki.2008.166_bb0115","doi-asserted-by":"crossref","first-page":"1639","DOI":"10.1093\/ndt\/gfl840","article-title":"Implementation of \u2018K\/DOQI Clinical Practice Guidelines for Bone Metabolism and Disease in Chronic Kidney Disease\u2019 after the introduction of cinacalcet in a population of patients on chronic haemodialysis","volume":"22","author":"Arenas","year":"2007","journal-title":"Nephrol Dial Transplant"},{"key":"10.1038\/ki.2008.166_bb0120","doi-asserted-by":"crossref","first-page":"2186","DOI":"10.1093\/ndt\/gfh966","article-title":"Long-term treatment of secondary hyperparathyroidism with the calcimimetic cinacalcet HCl","volume":"20","author":"Moe","year":"2005","journal-title":"Nephrol Dial Transplant"},{"key":"10.1038\/ki.2008.166_bb0125","doi-asserted-by":"crossref","first-page":"305","DOI":"10.2215\/CJN.00870805","article-title":"Cinacalcet hydrochloride (Sensipar) in hemodialysis patients on active vitamin D derivatives with controlled PTH and elevated calcium \u00d7 phosphate","volume":"1","author":"Chertow","year":"2006","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1038\/ki.2008.166_bb0130","doi-asserted-by":"crossref","first-page":"36","DOI":"10.2215\/CJN.03591006","article-title":"The optima study: assessing a new cinacalcet (Sensipar\/Mimpara) treatment algorithm for secondary hyperparathyroidism","volume":"3","author":"Messa","year":"2008","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1038\/ki.2008.166_bb0135","first-page":"IV 288","article-title":"The sensor study: a study to evaluate the efficacy of administering cinacalcet (Mimpara\/Sensipar) with the first meal after dialysis","volume":"21","author":"Schaefer","year":"2006","journal-title":"Nephrol Dial Transplant"},{"key":"10.1038\/ki.2008.166_bb0140","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1046\/j.1523-1755.2000.00178.x","article-title":"Increased risk of hip fracture among patients with end-stage renal disease","volume":"58","author":"Alem","year":"2000","journal-title":"Kidney Int"},{"key":"10.1038\/ki.2008.166_bb0145","doi-asserted-by":"crossref","first-page":"3377","DOI":"10.1093\/ndt\/gfm508","article-title":"Towards the prevention of bone fractures in dialysed patients?","volume":"22","author":"Jadoul","year":"2007","journal-title":"Nephrol Dial Transplant"},{"key":"10.1038\/ki.2008.166_bb0150","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1046\/j.1523-1755.1998.00782.x","article-title":"NPS R-568 halts or reverses osteitis fibrosa in uremic rats","volume":"53","author":"Wada","year":"1998","journal-title":"Kidney Int"},{"key":"10.1038\/ki.2008.166_bb0155","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1038\/ki.1993.64","article-title":"The spectrum of bone disease in end-stage renal failure\u2013\u2013an evolving disorder","volume":"43","author":"Sherrard","year":"1993","journal-title":"Kidney Int"},{"key":"10.1038\/ki.2008.166_bb0160","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1016\/S0002-9629(15)40554-3","article-title":"Relative hypoparathyroidism and adynamic bone disease","volume":"317","author":"Mucsi","year":"1999","journal-title":"Am J Med Sci"},{"key":"10.1038\/ki.2008.166_bb0165","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1093\/oxfordjournals.ndt.a027457","article-title":"Low serum levels of alkaline phosphatase of bone origin: a good marker of adynamic bone disease in haemodialysis patients","volume":"11","author":"Couttenye","year":"1996","journal-title":"Nephrol Dial Transplant"},{"key":"10.1038\/ki.2008.166_bb0170","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1093\/ndt\/gfg116","article-title":"Spectrum of renal bone disease in end-stage renal failure patients not yet on dialysis","volume":"18","author":"Spasovski","year":"2003","journal-title":"Nephrol Dial Transplant"},{"key":"10.1038\/ki.2008.166_bb0175","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1002\/jbmr.5650100121","article-title":"Risk factors for renal osteodystrophy: a multivariant analysis","volume":"10","author":"Pei","year":"1995","journal-title":"J Bone Miner Res"},{"key":"10.1038\/ki.2008.166_bb0180","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1016\/0272-6386(95)90599-5","article-title":"Predictive value of serum parathyroid hormone levels for bone turnover in patients on chronic maintenance dialysis","volume":"26","author":"Qi","year":"1995","journal-title":"Am J Kidney Dis"},{"key":"10.1038\/ki.2008.166_bb0185","first-page":"s62","article-title":"Risk of adynamic bone disease in dialyzed patients","volume":"38","author":"Malluche","year":"1992","journal-title":"Kidney Int"},{"key":"10.1038\/ki.2008.166_bb0190","doi-asserted-by":"crossref","first-page":"1943","DOI":"10.1097\/01.ASN.0000129337.50739.48","article-title":"Arterial calcifications and bone histomorphometry in end-stage renal disease","volume":"15","author":"London","year":"2004","journal-title":"J Am Soc Nephrol"},{"key":"10.1038\/ki.2008.166_bb0195","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1053\/j.ajkd.2005.09.024","article-title":"PTH and the risks for hip, vertebral, and pelvic fractures among patients on dialysis","volume":"47","author":"Danese","year":"2006","journal-title":"Am J Kidney Dis"},{"key":"10.1038\/ki.2008.166_bb0200","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1053\/ajkd.2000.19812","article-title":"Increased incidence of hip fractures in dialysis patients with low serum parathyroid hormone","volume":"36","author":"Coco","year":"2000","journal-title":"Am J Kidney Dis"},{"key":"10.1038\/ki.2008.166_bb0205","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/S8756-3282(99)00263-X","article-title":"Daily intermittent decreases in serum levels of parathyroid hormone have an anabolic-like action on the bones of uremic rats with low-turnover bone and osteomalacia","volume":"26","author":"Ishii","year":"2000","journal-title":"Bone"},{"key":"10.1038\/ki.2008.166_bb0210","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1016\/S8756-3282(00)00350-1","article-title":"Daily transient decreases in plasma parathyroid hormone levels induced by the calcimimetic NPS R-568 slows the rate of bone loss but does not increase bone mass in ovariectomized rats","volume":"27","author":"Miller","year":"2000","journal-title":"Bone"},{"key":"10.1038\/ki.2008.166_bb0215","doi-asserted-by":"crossref","first-page":"1577","DOI":"10.1210\/endo.132.4.8462456","article-title":"The effect of recombinant human (1\u201384) or synthetic human (1\u201334) parathyroid hormone on the skeleton of adult osteopenic ovariectomized rats","volume":"132","author":"Kimmel","year":"1993","journal-title":"Endocrinology"},{"key":"10.1038\/ki.2008.166_bb0220","doi-asserted-by":"crossref","first-page":"1484","DOI":"10.1046\/j.1523-1755.2000.00993.x","article-title":"Intermittent administration of parathyroid hormone (1\u201337) improves growth and bone mineral density in uremic rats","volume":"57","author":"Schmitt","year":"2000","journal-title":"Kidney Int"},{"key":"10.1038\/ki.2008.166_bb0225","first-page":"M016","article-title":"Cinacalcet HCl reduces bone turnover and bone marrow fibrosis in hemodialysis patients with secondary hyperparathryoidism","volume":"2004","author":"Malluche","year":"2004","journal-title":"Nephrol Dial Transplant"},{"key":"10.1038\/ki.2008.166_bb0230","doi-asserted-by":"crossref","first-page":"1232","DOI":"10.1093\/ndt\/gfh829","article-title":"Effects of cinacalcet on bone mineral density in patients with secondary hyperparathyroidism","volume":"20","author":"Lien","year":"2005","journal-title":"Nephrol Dial Transplant"},{"key":"10.1038\/ki.2008.166_bb0235","doi-asserted-by":"crossref","first-page":"1793","DOI":"10.1111\/j.1523-1755.2005.00596.x","article-title":"Effects of the calcimimetic cinacalcet HCl on cardiovascular disease, fracture, and health-related quality of life in secondary hyperparathyroidism","volume":"68","author":"Cunningham","year":"2005","journal-title":"Kidney Int"},{"key":"10.1038\/ki.2008.166_bb0240","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1038\/sj.ki.5002059","article-title":"Mortality effect of coronary calcification and phosphate binder choice in incident hemodialysis patients","volume":"71","author":"Block","year":"2007","journal-title":"Kidney Int"},{"key":"10.1038\/ki.2008.166_bb0245","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1161\/hy1001.096358","article-title":"Arterial calcifications, arterial stiffness, and cardiovascular risk in end-stage renal disease","volume":"38","author":"Blacher","year":"2001","journal-title":"Hypertension"},{"key":"10.1038\/ki.2008.166_bb0250","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1097\/01.ASN.0000038685.95946.83","article-title":"Cardiac valve calcification as an important predictor for all-cause mortality and cardiovascular mortality in long-term peritoneal dialysis patients: a prospective study","volume":"13","author":"Wang","year":"2003","journal-title":"J Am Soc Nephrol"},{"key":"10.1038\/ki.2008.166_bb0255","doi-asserted-by":"crossref","first-page":"1731","DOI":"10.1093\/ndt\/gfg414","article-title":"Arterial media calcification in end-stage renal disease: impact on all-cause and cardiovascular mortality","volume":"18","author":"London","year":"2003","journal-title":"Nephrol Dial Transplant"},{"key":"10.1038\/ki.2008.166_bb0260","doi-asserted-by":"crossref","first-page":"2959","DOI":"10.1097\/01.ASN.0000145894.57533.C4","article-title":"Vascular calcification mechanisms","volume":"15","author":"Giachelli","year":"2004","journal-title":"J Am Soc Nephrol"},{"key":"10.1038\/ki.2008.166_bb0265","doi-asserted-by":"crossref","first-page":"1262","DOI":"10.1038\/sj.ki.5002241","article-title":"Vascular calcification: contribution of parathyroid hormone in renal failure","volume":"71","author":"Neves","year":"2007","journal-title":"Kidney Int"},{"key":"10.1038\/ki.2008.166_bb0270","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.1093\/ndt\/15.7.1014","article-title":"Arterial stiffening and vascular calcifications in end-stage renal disease","volume":"15","author":"Guerin","year":"2000","journal-title":"Nephrol Dial Transplant"},{"key":"10.1038\/ki.2008.166_bb0275","doi-asserted-by":"crossref","first-page":"1478","DOI":"10.1056\/NEJM200005183422003","article-title":"Coronary-artery calcification in young adults with end-stage renal disease who are undergoing dialysis","volume":"342","author":"Goodman","year":"2000","journal-title":"N Engl J Med"},{"key":"10.1038\/ki.2008.166_bb0280","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1093\/ndt\/gfm660","article-title":"Associations between vascular calcification, arterial stiffness and bone mineral density in chronic kidney disease","volume":"23","author":"Toussaint","year":"2008","journal-title":"Nephrol Dial Transplant"},{"key":"10.1038\/ki.2008.166_bb0285","doi-asserted-by":"crossref","first-page":"1278","DOI":"10.1161\/HYPERTENSIONAHA.107.086942","article-title":"Pulse wave velocity is inversely related to vertebral bone density in hemodialysis patients","volume":"49","author":"Raggi","year":"2007","journal-title":"Hypertension"},{"key":"10.1038\/ki.2008.166_bb0290","doi-asserted-by":"crossref","first-page":"697","DOI":"10.2215\/CJN.00560206","article-title":"The case against calcium-based phosphate binders","volume":"1","author":"Moe","year":"2006","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1038\/ki.2008.166_bb0295","doi-asserted-by":"crossref","first-page":"1370","DOI":"10.1093\/ndt\/gfh834","article-title":"1,25-Dihydroxyvitamin D3 but not cinacalcet HCl (Sensipar(R)\/Mimpara(R)) treatment mediates aortic calcification in a rat model of secondary hyperparathyroidism","volume":"20","author":"Henley","year":"2005","journal-title":"Nephrol Dial Transplant"},{"key":"10.1038\/ki.2008.166_bb0300","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1681\/ASN.2005040342","article-title":"Calcimimetic R-568 decreases extraosseous calcifications in uremic rats treated with calcitriol","volume":"17","author":"Lopez","year":"2006","journal-title":"J Am Soc Nephrol"},{"key":"10.1038\/ki.2008.166_bb0305","doi-asserted-by":"crossref","first-page":"2724","DOI":"10.1093\/ndt\/gfm312","article-title":"Calcimimetic increases osteoprotegerin and decreases fetuin-A levels in dialysis patients","volume":"22","author":"Messa","year":"2007","journal-title":"Nephrol Dial Transplant"},{"key":"10.1038\/ki.2008.166_bb0310","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.1111\/j.1523-1755.2004.00895.x","article-title":"Vascular calcification: a stiff challenge for the nephrologist","volume":"66","author":"Goldsmith","year":"2004","journal-title":"Kidney Int"},{"key":"10.1038\/ki.2008.166_bb0315","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1016\/S0140-6736(03)12710-9","article-title":"Association of low fetuin-A (AHSG) concentrations in serum with cardiovascular mortality in patients on dialysis: a cross-sectional study","volume":"361","author":"Ketteler","year":"2003","journal-title":"Lancet"},{"key":"10.1038\/ki.2008.166_bb0320","doi-asserted-by":"crossref","first-page":"2175","DOI":"10.1161\/01.CIR.0000127957.43874.BB","article-title":"Osteoprotegerin is a risk factor for progressive atherosclerosis and cardiovascular disease","volume":"109","author":"Kiechl","year":"2004","journal-title":"Circulation"},{"key":"10.1038\/ki.2008.166_bb0325","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.1111\/j.1523-1755.2005.00172.x","article-title":"Serum fetuin-A in nondialyzed patients with diabetic nephropathy: relationship with coronary artery calcification","volume":"67","author":"Mehrotra","year":"2005","journal-title":"Kidney Int"},{"key":"10.1038\/ki.2008.166_bb0330","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1097\/01.ASN.0000056188.23717.E5","article-title":"Beneficial effects of calcimimetics on progression of renal failure and cardiovascular risk factors","volume":"14","author":"Ogata","year":"2003","journal-title":"J Am Soc Nephrol"},{"key":"10.1038\/ki.2008.166_bb0335","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1681\/ASN.2005090914","article-title":"Acute blood pressure effects and chronic hypotensive action of calcimimetics in uremic rats","volume":"17","author":"Odenwald","year":"2006","journal-title":"J Am Soc Nephrol"},{"key":"10.1038\/ki.2008.166_bb0340","doi-asserted-by":"crossref","first-page":"1714","DOI":"10.1093\/ndt\/gfh892","article-title":"Impact of parathyroidectomy on renal graft function, blood pressure and serum lipids in kidney transplant recipients: a single centre study","volume":"20","author":"Evenepoel","year":"2005","journal-title":"Nephrol Dial Transplant"},{"key":"10.1038\/ki.2008.166_bb0345","doi-asserted-by":"crossref","first-page":"1639","DOI":"10.1097\/01.hjh.0000179764.40701.36","article-title":"Serum parathyroid hormone as a predictor of increase in systolic blood pressure in men","volume":"23","author":"Jorde","year":"2005","journal-title":"J Hypertens"},{"key":"10.1038\/ki.2008.166_bb0350","doi-asserted-by":"crossref","first-page":"1633","DOI":"10.1097\/01.hjh.0000179508.84479.90","article-title":"Parathyroid hormone and hypertension","volume":"23","author":"Nyirenda","year":"2005","journal-title":"J Hypertens"},{"key":"10.1038\/ki.2008.166_bb0355","doi-asserted-by":"crossref","first-page":"s33","DOI":"10.1111\/j.1523-1755.2005.09505.x","article-title":"Calcimimetics: a new tool for management of hyperparathyroidism and renal osteodystrophy in patients with chronic kidney disease","volume":"67","author":"Lindberg","year":"2005","journal-title":"Kidney Int"},{"key":"10.1038\/ki.2008.166_bb0360","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1038\/ki.1990.58","article-title":"Excess parathyroid hormone adversely affects lipid metabolism in chronic renal failure","volume":"37","author":"Akmal","year":"1990","journal-title":"Kidney Int"},{"key":"10.1038\/ki.2008.166_bb0365","doi-asserted-by":"crossref","first-page":"2167","DOI":"10.1172\/JCI118657","article-title":"Abnormalities in hepatic lipase in chronic renal failure. Role of excess parathyroid hormone","volume":"97","author":"Klin","year":"1996","journal-title":"J Clin Invest"},{"key":"10.1038\/ki.2008.166_bb0370","doi-asserted-by":"crossref","first-page":"E373","DOI":"10.1152\/ajpendo.1986.250.4.E373","article-title":"Correction by insulin of disturbed TG-rich LP metabolism in rats with chronic renal failure","volume":"250","author":"Roullet","year":"1986","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"10.1038\/ki.2008.166_bb0375","doi-asserted-by":"crossref","first-page":"898","DOI":"10.2215\/CJN.04381206","article-title":"Evaluation of cinacalcet therapy to lower cardiovascular events (EVOLVE): rationale and design overview","volume":"2","author":"Chertow","year":"2007","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1038\/ki.2008.166_bb0380","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1056\/NEJMoa043545","article-title":"Atorvastatin in patients with type 2 diabetes mellitus undergoing hemodialysis","volume":"353","author":"Wanner","year":"2005","journal-title":"N Engl J Med"},{"key":"10.1038\/ki.2008.166_bb0385","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1056\/NEJM199808273390903","article-title":"The effects of normal as compared with low hematocrit values in patients with cardiac disease who are receiving hemodialysis and epoetin","volume":"339","author":"Besarab","year":"1998","journal-title":"N Engl J Med"},{"key":"10.1038\/ki.2008.166_bb0390","doi-asserted-by":"crossref","first-page":"2010","DOI":"10.1056\/NEJMoa021583","article-title":"Effect of dialysis dose and membrane flux in maintenance hemodialysis","volume":"347","author":"Eknoyan","year":"2002","journal-title":"N Engl J Med"},{"key":"10.1038\/ki.2008.166_bb0395","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.1038\/sj.ki.5002466","article-title":"Effects of sevelamer and calcium-based phosphate binders on mortality in hemodialysis patients","volume":"72","author":"Suki","year":"2007","journal-title":"Kidney Int"},{"key":"10.1038\/ki.2008.166_bb0400","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1093\/ndt\/gfl718","article-title":"Mineral metabolism parameters throughout chronic kidney disease stages 1\u20135\u2013\u2013achievement of K\/DOQI target ranges","volume":"22","author":"Craver","year":"2007","journal-title":"Nephrol Dial Transplant"},{"key":"10.1038\/ki.2008.166_bb0405","doi-asserted-by":"crossref","first-page":"2205","DOI":"10.1681\/ASN.2005010052","article-title":"Fibroblast growth factor-23 mitigates hyperphosphatemia but accentuates calcitriol deficiency in chronic kidney disease","volume":"16","author":"Gutierrez","year":"2005","journal-title":"J Am Soc Nephrol"},{"key":"10.1038\/ki.2008.166_bb0410","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1038\/sj.ki.5002009","article-title":"Prevalence of abnormal serum vitamin D, PTH, calcium, and phosphorus in patients with chronic kidney disease: results of the study to evaluate early kidney disease","volume":"71","author":"Levin","year":"2007","journal-title":"Kidney Int"},{"key":"10.1038\/ki.2008.166_bb0415","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1146\/annurev.physiol.69.040705.141729","article-title":"Phosphatonins and the regulation of phosphate homeostasis","volume":"69","author":"Berndt","year":"2007","journal-title":"Annu Rev Physiol"},{"key":"10.1038\/ki.2008.166_bb0420","doi-asserted-by":"crossref","first-page":"1637","DOI":"10.1681\/ASN.2007010068","article-title":"How fibroblast growth factor 23 works","volume":"18","author":"Liu","year":"2007","journal-title":"J Am Soc Nephrol"},{"key":"10.1038\/ki.2008.166_bb0425","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1053\/j.ajkd.2004.04.029","article-title":"Possible involvement of circulating fibroblast growth factor 23 in the development of secondary hyperparathyroidism associated with renal insufficiency","volume":"44","author":"Shigematsu","year":"2004","journal-title":"Am J Kidney Dis"},{"key":"10.1038\/ki.2008.166_bb0430","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1359\/JBMR.0301264","article-title":"FGF-23 is a potent regulator of vitamin D metabolism and phosphate homeostasis","volume":"19","author":"Shimada","year":"2004","journal-title":"Bone Miner Res"},{"key":"10.1038\/ki.2008.166_bb0435","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1001\/archinte.1969.00300190042007","article-title":"The physicochemical state and renal handling of divalent ions in chronic renal failure","volume":"124","author":"Coburn","year":"1969","journal-title":"Arch Int Med"},{"key":"10.1038\/ki.2008.166_bb0440","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1038\/ki.1973.40","article-title":"Study of intestinal absorption of calcium in patients with renal failure","volume":"3","author":"Coburn","year":"1973","journal-title":"Kidney Int"},{"key":"10.1038\/ki.2008.166_bb0445","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1042\/cs0380297","article-title":"Divalent ion excretion in chronic kidney disease: relation to degree of renal insufficiency","volume":"38","author":"Popovtzer","year":"1970","journal-title":"Clin Sci"},{"key":"10.1038\/ki.2008.166_bb0450","doi-asserted-by":"crossref","DOI":"10.1038\/sj.ki.5002287","article-title":"Development and progression of secondary hyperparathyroidism in chronic kidney disease: lessons from molecular genetics","author":"Goodman","year":"2008","journal-title":"Kidney Int"},{"key":"10.1038\/ki.2008.166_bb0455","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1038\/ki.1973.92","article-title":"The role of phosphorus restriction in the prevention of secondary hyperparathyroidism in chronic renal disease","volume":"4","author":"Slatopolsky","year":"1973","journal-title":"Kidney Int"},{"key":"10.1038\/ki.2008.166_bb0460","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1053\/j.ajkd.2005.04.013","article-title":"Cinacalcet hydrochloride is an effective treatment for secondary hyperparathyroidism in patients with CKD not receiving dialysis","volume":"46","author":"Charytan","year":"2005","journal-title":"Am J Kidney Dis"},{"key":"10.1038\/ki.2008.166_bb0465","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1093\/ndt\/gfl560","article-title":"Effective control of persistent hyperparathyroidism with cinacalcet in renal allograft recipients","volume":"22","author":"Serra","year":"2007","journal-title":"Nephrol Dial Transplant"},{"key":"10.1038\/ki.2008.166_bb0470","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1038\/ki.1993.228","article-title":"Parathyroid removal prevents the progression of chronic renal failure induced by high protein diet","volume":"44","author":"Shigematsu","year":"1993","journal-title":"Kidney Int"},{"key":"10.1038\/ki.2008.166_bb0475","doi-asserted-by":"crossref","first-page":"1995","DOI":"10.1111\/j.1476-5381.1996.tb15635.x","article-title":"Effect of intrarenally infused parathyroid hormone-related protein on renal blood flow and glomerular filtration rate in the anaesthetized rat","volume":"118","author":"Massfelder","year":"1996","journal-title":"Br J Pharmacol"},{"key":"10.1038\/ki.2008.166_bb0480","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1038\/ki.1989.281","article-title":"Phosphate excess and progressive renal failure: the precipitation\u2013calcification hypothesis","volume":"36","author":"Lau","year":"1989","journal-title":"Kidney Int"},{"key":"10.1038\/ki.2008.166_bb0485","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1007\/s10157-004-0292-0","article-title":"Crystal-induced inflammation of the kidneys: results from human studies, animal models, and tissue-culture studies","volume":"8","author":"Khan","year":"2004","journal-title":"Clin Exp Nephrol"},{"key":"10.1038\/ki.2008.166_bb0490","doi-asserted-by":"crossref","first-page":"1684","DOI":"10.1111\/j.1523-1755.2004.00564.x","article-title":"Effect of the calcimimetic NPS R-467 on furosemide-induced nephrocalcinosis in the young rat","volume":"65","author":"Pattaragarn","year":"2004","journal-title":"Kidney Int"},{"key":"10.1038\/ki.2008.166_bb0495","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1111\/j.1440-1797.2003.00212.x","article-title":"Prevalence of vascular risk factors and vascular disease in predialysis chronic renal failure","volume":"8","author":"Kohlhagen","year":"2003","journal-title":"Nephrology (Carlton)"},{"key":"10.1038\/ki.2008.166_bb0500","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1681\/ASN.2004070602","article-title":"Serum phosphate levels and mortality risk among people with chronic kidney disease","volume":"16","author":"Kestenbaum","year":"2005","journal-title":"J Am Soc Nephrol"},{"key":"10.1038\/ki.2008.166_bb0505","doi-asserted-by":"crossref","first-page":"2909","DOI":"10.1093\/ndt\/gfm286","article-title":"High plasma phosphate as a risk factor for decline in renal function and mortality in pre-dialysis patients","volume":"22","author":"Voormolen","year":"2007","journal-title":"Nephrol Dial Transplant"},{"key":"10.1038\/ki.2008.166_bb0510","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1038\/nature05315","article-title":"Klotho converts canonical FGF receptor into a specific receptor for FGF23","volume":"444","author":"Urakawa","year":"2006","journal-title":"Nature"},{"key":"10.1038\/ki.2008.166_bb0515","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1097\/01.mnh.0000232885.81142.83","article-title":"Klotho as a regulator of fibroblast growth factor signaling and phosphate\/calcium metabolism","volume":"15","author":"Kuro-o","year":"2006","journal-title":"Curr Opin Nephrol Hypertens"},{"key":"10.1038\/ki.2008.166_bb0520","doi-asserted-by":"crossref","first-page":"3182","DOI":"10.1093\/jn\/131.12.3182","article-title":"The progression of aging in Klotho mutant mice can be modified by dietary phosphorus and zinc","volume":"131","author":"Morishita","year":"2001","journal-title":"J Nutr"},{"key":"10.1038\/ki.2008.166_bb0525","doi-asserted-by":"crossref","first-page":"1704","DOI":"10.1046\/j.1523-1755.1998.00142.x","article-title":"Persistent secondary hyperparathyroidism after renal transplantation","volume":"54","author":"Messa","year":"1998","journal-title":"Kidney Int"},{"key":"10.1038\/ki.2008.166_bb0530","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1046\/j.1523-1755.1999.00589.x","article-title":"Reduced parathyroid functional mass after successful kidney transplantation","volume":"56","author":"Bonarek","year":"1999","journal-title":"Kidney Int"},{"key":"10.1038\/ki.2008.166_bb0535","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1600-6143.2007.01753.x","article-title":"Tertiary \u2018hyperphosphatoninism\u2019 accentuates hypophosphatemia and suppresses calcitriol levels in renal transplant recipients","volume":"7","author":"Evenepoel","year":"2007","journal-title":"Am J Transplant"},{"key":"10.1038\/ki.2008.166_bb0540","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.1093\/ndt\/gfh128","article-title":"Natural history of parathyroid function and calcium metabolism after kidney transplantation: a single-centre study","volume":"19","author":"Evenepoel","year":"2004","journal-title":"Nephrol Dial Transplant"},{"key":"10.1038\/ki.2008.166_bb0545","first-page":"92","article-title":"Hypercalcemic hyperparathyroidism following renal transplantation: differential diagnosis, management, and implications for cell population control in the parathyroid gland","volume":"8","author":"Parfitt","year":"1982","journal-title":"Miner Electrolyte Metab"},{"key":"10.1038\/ki.2008.166_bb0550","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1093\/oxfordjournals.ndt.a027843","article-title":"Sequential changes of biochemical bone parameters after kidney transplantation","volume":"13","author":"Reinhardt","year":"1998","journal-title":"Nephrol Dial Transplant"},{"key":"10.1038\/ki.2008.166_bb0555","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1097\/01.mnh.0000203187.49890.cc","article-title":"Post-renal transplantation hypophosphatemia: a review and novel insights","volume":"15","author":"Ghanekar","year":"2006","journal-title":"Curr Opin Nephrol Hypertens"},{"key":"10.1038\/ki.2008.166_bb0560","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1097\/01.TP.0000043926.74349.6D","article-title":"Bone disease after renal transplantation","volume":"75","author":"Heaf","year":"2003","journal-title":"Transplantation"},{"key":"10.1038\/ki.2008.166_bb0565","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1093\/ndt\/gfg029","article-title":"Bone disease after renal transplantation","volume":"18","author":"Sperschneider","year":"2003","journal-title":"Nephrol Dial Transplant"},{"key":"10.1038\/ki.2008.166_bb0570","first-page":"749A","article-title":"Parathyroid hormone accentuates hypercalcemia and elevated calcitriol levels in renal transplant recipients in the early posttransplant period","volume":"18","author":"Evenepoel","year":"2007","journal-title":"J Am Soc Nephrol"},{"key":"10.1038\/ki.2008.166_bb0575","doi-asserted-by":"crossref","first-page":"1934","DOI":"10.1111\/j.1600-6143.2005.00938.x","article-title":"Early calcification of renal allografts detected by protocol biopsies: causes and clinical implications","volume":"5","author":"Gwinner","year":"2005","journal-title":"Am J Transplant"},{"key":"10.1038\/ki.2008.166_bb0580","doi-asserted-by":"crossref","first-page":"2362","DOI":"10.1093\/ndt\/gfm270","article-title":"Effect of cinacalcet cessation in renal transplant recipients with persistent hyperparathyroidism","volume":"22","author":"Kruse","year":"2007","journal-title":"Nephrol Dial Transplant"},{"key":"10.1038\/ki.2008.166_bb0585","doi-asserted-by":"crossref","first-page":"323","DOI":"10.2215\/CJN.00500705","article-title":"Improvement in hypercalcemia with cinacalcet after kidney transplantation","volume":"1","author":"Srinivas","year":"2006","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1038\/ki.2008.166_bb0590","doi-asserted-by":"crossref","first-page":"2391","DOI":"10.1111\/j.1600-6143.2006.01475.x","article-title":"Early and severe hyperparathyroidism associated with hypercalcemia after renal transplant treated with cinacalcet","volume":"6","author":"Leca","year":"2006","journal-title":"Am J Transplant"},{"key":"10.1038\/ki.2008.166_bb0595","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1097\/01.tp.0000253429.33198.2f","article-title":"Preliminary experience with cinacalcet use in persistent secondary hyperparathyroidism after kidney transplantation","volume":"83","author":"El-Amm","year":"2007","journal-title":"Transplantation"},{"key":"10.1038\/ki.2008.166_bb0600","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1097\/01.tp.0000232452.80018.ad","article-title":"Cinacalcet chloride is efficient and safe in renal transplant recipients with posttransplant hyperparathyroidism","volume":"82","author":"Szwarc","year":"2006","journal-title":"Transplantation"},{"key":"10.1038\/ki.2008.166_bb0605","doi-asserted-by":"crossref","first-page":"2254","DOI":"10.1016\/j.transproceed.2007.07.079","article-title":"Cinacalcet for the treatment of hypercalcemia in renal transplanted patients with secondary hyperparathyroidism","volume":"39","author":"Bergua","year":"2007","journal-title":"Transplant Proc"},{"key":"10.1038\/ki.2008.166_bb0610","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/S8756-3282(97)00002-1","article-title":"Calcium-receptor-regulated parathyroid and renal function","volume":"20","author":"Brown","year":"1997","journal-title":"Bone"},{"key":"10.1038\/ki.2008.166_bb0615","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.1093\/ndt\/gfm632","article-title":"Cinacalcet's effect on the pharmacokinetics of tacrolimus, cyclosporine and mycophenolate in renal transplant recipients","volume":"23","author":"Falck","year":"2008","journal-title":"Nephrol Dial Transplant"},{"key":"10.1038\/ki.2008.166_bb0620","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1093\/ndt\/gfl583","article-title":"Decreased renal transplant function after parathyroidectomy","volume":"22","author":"Schwarz","year":"2007","journal-title":"Nephrol Dial Transplant"},{"key":"10.1038\/ki.2008.166_bb0625","doi-asserted-by":"crossref","first-page":"1730","DOI":"10.1093\/ndt\/gfm044","article-title":"Parathyroidectomy after successful kidney transplantation: a single centre study","volume":"22","author":"Evenepoel","year":"2007","journal-title":"Nephrol Dial Transplant"},{"key":"10.1038\/ki.2008.166_bb0630","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1517\/14622416.6.1.37","article-title":"Cytochrome P450 3A polymorphisms and immunosuppressive drugs","volume":"6","author":"Thervet","year":"2005","journal-title":"Pharmacogenomics J"},{"key":"10.1038\/ki.2008.166_bb0635","doi-asserted-by":"crossref","first-page":"1828","DOI":"10.1093\/ndt\/gfm177","article-title":"Can calcimimetics inhibit parathyroid hyperplasia? Evidence from preclinical studies","volume":"22","author":"Drueke","year":"2007","journal-title":"Nephrol Dial Transplant"},{"key":"10.1038\/ki.2008.166_bb0640","doi-asserted-by":"crossref","first-page":"2977","DOI":"10.1172\/JCI119851","article-title":"The calcimimetic compound NPS R-568 suppresses parathyroid cell proliferation in rats with renal insufficiency. Control of parathyroid cell growth via a calcium receptor","volume":"100","author":"Wada","year":"1997","journal-title":"J Clin Invest"},{"key":"10.1038\/ki.2008.166_bb0645","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1111\/j.1523-1755.2005.67103.x","article-title":"Cinacalcet HCl attenuates parathyroid hyperplasia in a rat model of secondary hyperparathyroidism","volume":"67","author":"Colloton","year":"2005","journal-title":"Kidney Int"},{"key":"10.1038\/ki.2008.166_bb0650","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1681\/ASN.V115903","article-title":"Activation of the calcium receptor by a calcimimetic compound halts the progression of secondary hyperparathyroidism in uremic rats","volume":"11","author":"Chin","year":"2000","journal-title":"J Am Soc Nephrol"},{"key":"10.1038\/ki.2008.166_bb0655","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.bbrc.2007.07.177","article-title":"Activation of calcium-sensing receptor accelerates apoptosis in hyperplastic parathyroid cells","volume":"362","author":"Mizobuchi","year":"2007","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1038\/ki.2008.166_bb0660","doi-asserted-by":"crossref","first-page":"1663","DOI":"10.1038\/ki.1996.483","article-title":"Non-suppressible parathyroid hormone secretion is related to gland size in uremic secondary hyperparathyroidism","volume":"50","author":"Indridason","year":"1996","journal-title":"Kidney Int"},{"key":"10.1038\/ki.2008.166_bb0665","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1038\/ki.1982.227","article-title":"Parathyroid function in persistent hyperparathyroidism: relationship to gland size","volume":"22","author":"McCarron","year":"1982","journal-title":"Kidney Int"},{"key":"10.1038\/ki.2008.166_bb0670","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1016\/j.clinthera.2007.02.002","article-title":"Cinacalcet-associated cardiogenic shock in a patient with cardiomyopathy","volume":"29","author":"Tilling","year":"2007","journal-title":"Clin Ther"},{"key":"10.1038\/ki.2008.166_bb0675","doi-asserted-by":"crossref","first-page":"65","DOI":"10.5414\/CNP65065","article-title":"Reversible hypocalcemic heart failure with T wave alternans and increased QTc dispersion in a patient with chronic renal failure after parathyroidectomy","volume":"65","author":"Iwazu","year":"2006","journal-title":"Clin Nephrol"},{"key":"10.1038\/ki.2008.166_bb0680","first-page":"583","article-title":"Hypophosphatemia and hungry bone syndrome in a dialysis patient with secondary hyperparathyroidism treated with cinacalcet\u2013\u2013proposal for an improved monitoring","volume":"52","author":"Nowack","year":"2006","journal-title":"Clin Lab"},{"key":"10.1038\/ki.2008.166_bb0685","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1111\/j.1525-139X.2007.00248.x","article-title":"Cinacalcet-induced hungry bone syndrome","volume":"20","author":"Lazar","year":"2007","journal-title":"Semin Dial"},{"key":"10.1038\/ki.2008.166_bb0690","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1016\/S0272-6386(03)00909-0","article-title":"Changes of bone remodeling immediately after parathyroidectomy for secondary hyperparathyroidism","volume":"42","author":"Yajima","year":"2003","journal-title":"Am J Kidney Dis"},{"key":"10.1038\/ki.2008.166_bb0695","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1016\/S0272-6386(97)90131-1","article-title":"Biochemical aberrations in a dialysis patient following parathyroidectomy","volume":"29","author":"Cruz","year":"1997","journal-title":"Am J Kidney Dis"},{"key":"10.1038\/ki.2008.166_bb0700","doi-asserted-by":"crossref","first-page":"1626","DOI":"10.1681\/ASN.V8101626","article-title":"Severe hyperparathyroidism associated with prolonged hungry bone syndrome in a renal transplant recipient","volume":"8","author":"Miles","year":"1997","journal-title":"J Am Soc Nephrol"},{"key":"10.1038\/ki.2008.166_bb0705","doi-asserted-by":"crossref","first-page":"1491","DOI":"10.1124\/dmd.104.000604","article-title":"Metabolism and disposition of calcimimetic agent cinacalcet HCl in humans and animal models","volume":"32","author":"Kumar","year":"2004","journal-title":"Drug Metab Dispos"},{"key":"10.1038\/ki.2008.166_bb0710","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.1053\/j.ajkd.2004.08.029","article-title":"Pharmacokinetics, pharmacodynamics, and safety of cinacalcet hydrochloride in hemodialysis patients at doses up to 200mg once daily","volume":"44","author":"Harris","year":"2004","journal-title":"Am J Kidney Dis"},{"key":"10.1038\/ki.2008.166_bb0715","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1111\/j.1365-2125.2004.02088.x","article-title":"The calcimimetic agent KRN 1493 lowers plasma parathyroid hormone and ionized calcium concentrations in patients with chronic renal failure on haemodialysis both on the day of haemodialysis and on the day without haemodialysis","volume":"57","author":"Ohashi","year":"2004","journal-title":"Br J Clin Pharmacol"},{"key":"10.1038\/ki.2008.166_bb0720","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1210\/jc.2004-0842","article-title":"Cinacalcet hydrochloride maintains long-term normocalcemia in patients with primary hyperparathyroidism","volume":"90","author":"Peacock","year":"2005","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1038\/ki.2008.166_bb0725","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1159\/000045976","article-title":"Parathyroidectomy in chronic renal failure: short- and long-term results on parathyroid function, blood pressure and anemia","volume":"88","author":"Coen","year":"2001","journal-title":"Nephron"},{"key":"10.1038\/ki.2008.166_bb0730","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1136\/pgmj.2004.026450","article-title":"Four gland parathyroidectomy without reimplantation in patients with chronic renal failure","volume":"81","author":"Saunders","year":"2005","journal-title":"Postgrad Med J"},{"key":"10.1038\/ki.2008.166_bb0735","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1159\/000057440","article-title":"Long-term results of total parathyroidectomy without autotransplantation in patients with and without renal failure","volume":"25","author":"Hampl","year":"1999","journal-title":"Miner Electrolyte Metab"},{"key":"10.1038\/ki.2008.166_bb0740","doi-asserted-by":"crossref","first-page":"S76","DOI":"10.1046\/j.1442-2042.2001.00340.x","article-title":"Development of low-turnover bone diseases after parathyroidectomy and autotransplantation","volume":"8","author":"Yajima","year":"2001","journal-title":"Int J Urol"},{"key":"10.1038\/ki.2008.166_bb0745","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1056\/NEJM198502213120803","article-title":"Effect of parathyroidectomy on bone aluminum accumulation in chronic renal failure","volume":"312","author":"Andress","year":"1985","journal-title":"N Engl J Med"},{"key":"10.1038\/ki.2008.166_bb0750","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1038\/ki.1985.27","article-title":"Effects of parathyroidectomy on bone formation and mineralization in hemodialyzed patients","volume":"27","author":"Charhon","year":"1985","journal-title":"Kidney Int"},{"key":"10.1038\/ki.2008.166_bb0755","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1093\/ndt\/11.supp3.29","article-title":"The aplastic form of renal osteodystrophy","volume":"11","author":"Sherrard","year":"1996","journal-title":"Nephrol Dial Transplant"},{"key":"10.1038\/ki.2008.166_bb0760","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1016\/S0272-6386(99)70305-7","article-title":"Clinical course after total parathyroidectomy without autotransplantation in patients with end-stage renal failure","volume":"33","author":"Stracke","year":"1999","journal-title":"Am J Kidney Dis"},{"key":"10.1038\/ki.2008.166_bb0765","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1055\/s-2003-39483","article-title":"Effect of parathyroidectomy on bone mineral density in hemodialysis patients with secondary hyperparathyroidism: possible usefulness of preoperative determination of parathyroid hormone level for prediction of bone regain","volume":"35","author":"Yano","year":"2003","journal-title":"Horm Metab Res"},{"key":"10.1038\/ki.2008.166_bb0770","doi-asserted-by":"crossref","first-page":"2401","DOI":"10.1681\/ASN.2007010022","article-title":"Fracture risk after parathyroidectomy among chronic hemodialysis patients","volume":"18","author":"Rudser","year":"2007","journal-title":"J Am Soc Nephrol"},{"key":"10.1038\/ki.2008.166_bb0775","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1053\/j.ajkd.2005.04.035","article-title":"Changes in cardiovascular calcification after parathyroidectomy in patients with ESRD","volume":"46","author":"Bleyer","year":"2005","journal-title":"Am J Kidney Dis"},{"key":"10.1038\/ki.2008.166_bb0780","doi-asserted-by":"crossref","first-page":"2010","DOI":"10.1111\/j.1523-1755.2004.00972.x","article-title":"Survival following parathyroidectomy among United States dialysis patients","volume":"66","author":"Kestenbaum","year":"2004","journal-title":"Kidney Int"},{"key":"10.1038\/ki.2008.166_bb0785","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1111\/j.1542-4758.2007.00155.x","article-title":"Clinical epidemiology of parathyroidectomy in hemodialysis patients: the USRDS Waves 1, 3, and 4 Study","volume":"11","author":"Slinin","year":"2007","journal-title":"Haemodial int"},{"key":"10.1038\/ki.2008.166_bb0790","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1111\/j.1440-1797.2005.00476.x","article-title":"Parathyroidectomy in the calcimimetic era","volume":"10","author":"Elder","year":"2005","journal-title":"Nephrology"},{"key":"10.1038\/ki.2008.166_bb0795","doi-asserted-by":"crossref","first-page":"2056","DOI":"10.1093\/ndt\/gfm156","article-title":"Cinacalcet is effective in relapses of secondary hyperparathyroidism after parathyroidectomy","volume":"22","author":"Lomonte","year":"2007","journal-title":"Nephrol Dial Transplant"},{"key":"10.1038\/ki.2008.166_bb0800","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1111\/j.1525-139X.2005.18417.x","article-title":"Cinacalcet cost and utility in dialysis patients","volume":"18","author":"Cohen","year":"2005","journal-title":"Semin Dial"},{"key":"10.1038\/ki.2008.166_bb0805","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1038\/ncpneph0191","article-title":"Drug insight: renal indications of calcimimetics","volume":"2","author":"Shahapuni","year":"2006","journal-title":"Nat Clin Pract Nephrol"},{"key":"10.1038\/ki.2008.166_bb0810","doi-asserted-by":"crossref","first-page":"1428","DOI":"10.1093\/ndt\/gfl774","article-title":"The cost\u2013utility of cinacalcet in addition to standard care compared to standard care alone for secondary hyperparathyroidism in end-stage renal disease: a UK perspective","volume":"22","author":"Garside","year":"2007","journal-title":"Nephrol Dial Transplant"},{"key":"10.1038\/ki.2008.166_bb0815","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1053\/j.ajkd.2007.03.009","article-title":"Parathyroidectomy versus cinacalcet hydrochloride-based medical therapy in the management of hyperparathyroidism in ESRD: a cost utility analysis","volume":"49","author":"Narayan","year":"2007","journal-title":"Am J Kidney Dis"},{"key":"10.1038\/ki.2008.166_bb0820","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1111\/j.1525-139X.2005.18318.x","article-title":"How do calcimimetics fit into the management of parathyroid hormone, calcium, and phosphate disturbances in dialysis patients?","volume":"18","author":"Shahapuni","year":"2005","journal-title":"Semin Dial"},{"key":"10.1038\/ki.2008.166_bb0825","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1056\/NEJMoa022536","article-title":"Survival of patients undergoing hemodialysis with paricalcitol or calcitriol therapy","volume":"349","author":"Teng","year":"2003","journal-title":"N Engl J Med"},{"key":"10.1038\/ki.2008.166_bb0830","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1111\/j.1525-139X.2005.18406.x","article-title":"Beyond minerals and parathyroid hormone: role of active vitamin D in end-stage renal disease","volume":"18","author":"Wolf","year":"2005","journal-title":"Semin Dial"},{"key":"10.1038\/ki.2008.166_bb0835","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1038\/sj.ki.5002451","article-title":"Vitamin D levels and early mortality among incident hemodialysis patients","volume":"72","author":"Wolf","year":"2007","journal-title":"Kidney Int"},{"key":"10.1038\/ki.2008.166_bb0840","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1038\/sj.ki.5002544","article-title":"Vitamin D as a novel nontraditional risk factor for mortality in hemodialysis patients: the need for randomized trials","volume":"72","author":"Al-Aly","year":"2007","journal-title":"Kidney Int"},{"key":"10.1038\/ki.2008.166_bb0845","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1681\/ASN.2004070573","article-title":"Activated injectable vitamin D and hemodialysis survival: a historical cohort study","volume":"16","author":"Teng","year":"2005","journal-title":"J Am Soc Nephrol"},{"key":"10.1038\/ki.2008.166_bb0850","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1161\/CIRCULATIONAHA.107.706127","article-title":"Vitamin D deficiency and risk of cardiovascular disease","volume":"117","author":"Wang","year":"2008","journal-title":"Circulation"},{"key":"10.1038\/ki.2008.166_bb0855","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1681\/ASN.2006121367","article-title":"Calciotropic hormones and arterial physiology: \u2018D\u2019-lightful insights","volume":"18","author":"Towler","year":"2007","journal-title":"J Am Soc Nephrol"}],"container-title":["Kidney International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0085253815533036?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0085253815533036?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,2,27]],"date-time":"2024-02-27T01:19:10Z","timestamp":1708996750000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0085253815533036"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,8]]},"references-count":170,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2008,8]]}},"alternative-id":["S0085253815533036"],"URL":"https:\/\/doi.org\/10.1038\/ki.2008.166","relation":{},"ISSN":["0085-2538"],"issn-type":[{"value":"0085-2538","type":"print"}],"subject":[],"published":{"date-parts":[[2008,8]]}}}